MSB 3.21% $1.13 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-717

  1. 16,916 Posts.
    lightbulb Created with Sketch. 8386
    "Want another game? Give me the number of children that have perished inthe last 2 years as a result of the Fda delay? despite efficacy been clearly and undeniably demonstrated."

    Not sure why you're asking me.
    I'm not an agent of the FDA, nor employed by the company to get the FDA to approve things.
    So you need to address that question to the company itself, and/or officials at the FDA.

    .
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.